Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer-Reference-Cited by-同舟云学术

Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer

Published:2009-04 Issue:2 Volume:8 Page:191-196
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Koontz Bridget F.,Chino Junzo,Lee W. Robert,Hahn Carol A.,Buckley Niall,Huang Samuel,Kim Jay,Reagan Robert,Joyner Raymond,Anscher Mitchell S.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference30 articles.

1. Palladium-103 brachytherapy for prostate carcinoma;Blasko;Int J Radiat Oncol Biol Phys,2000

2. Risk group stratification in patients undergoing permanent (125)I prostate brachytherapy as monotherapy;Kwok;Int J Radiat Oncol Biol Phys,2002

3. Five-year biochemical outcome and toxicity with transperineal ct-planned permanent I-125 prostate implantation for patients with localized prostate cancer;Zelefsky;Int J Radiat Oncol Biol Phys,2000

4. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998

5. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer;Potters;J Urol,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis;Technology and Health Care;2023-04-28

2. Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa);Cancer/Radiothérapie;2021-06

3. Radiation Therapy: Brachytherapy;Interventional Urology;2021

4. Prostate Cancer: Locoregional Disease;Practical Medical Oncology Textbook;2021

5. Biochemical outcomes and predictive factors by risk group after permanent iodine-125 seed implantation: Prospective cohort study in 2,316 patients;Brachytherapy;2019-09